Product Description

The literature on Dupuytren’s disease encompasses many specialties. Its treatment is generally by perforating, excising, or dissolving the affected tissues. This article reviews the changing understanding of this disease and treatment options.

Learning Objectives

After viewing this course, the participant should be able to:

• Understand updates in the basic science, epidemiology, and treatment of Dupuytren’s disease.
• Understand treatment with needle aponeurotomy, collagenase, and fasciectomy.
• Understand advanced needle techniques for Dupuytren’s contracture.
• Understand the safety and effectiveness of a new treatment, collagenase.

Faculty

Keith A. Denkler MD, Carolyn J. Vaughn MD, Estelle L. Dolan MD, Scott L. Hansen MD

Plastic and Reconstructive Surgery® Editors:

Editor-in-Chief: Rod J. Rohrich, MD

Co-Editor: James M. Stuzin, MD

Section Editor: Donald H. Lalonde, MD

Accreditation Information

AMA PRA Category 1 Credit^TM: 1.0

Patient Safety Credit: 0.5

Media: Journal Article, Video

Release Date: 12/28/2016

Expiration Date: 7/18/2022

Estimated time to complete this course: 1 hour

Directly provided by the American Society of Plastic Surgeons® (ASPS®)

Accreditation Statement

The American Society of Plastic Surgeons (ASPS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The ASPS designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Intended Audience

This educational activity is intended for plastic surgery practitioners, residents, and other healthcare professionals interested in translating expanded knowledge into practice for the improvement of patient outcomes in plastic and reconstructive surgery.

Disclosures

Dr. Rohrich, MD is the Principal/Co-Principal Investigator of research grants awarded to the University of Texas Southwestern Medical Center, Dallas, from Medicis, Mentor, and Contura Pharmaceutical. All research funds are provided directly to UT Southwestern. Dr. Stuzin has no relevant financial relationships or affiliations to disclose. Dr. Lalonde is a consultant for ASSI Instruments. None of the authors have any relevant financial relationships or affiliations to disclose. All ASPS staff members managing this activity have no relevant financial relationships or affiliations to disclose. All identified conflicts of interest have been resolved and the educational content thoroughly vetted by ASPS for fair balance, scientific objectivity, and appropriateness of patient care recommendations. The ASPS also requires faculty/authors to disclose when off-label/unapproved uses of a product are discussed in a CME activity or included in related materials.

Product Code: 20903